Over 3 million people in the U.S. live with Inappropriate Sinus Tachycardia (IST).​ For
those who are symptomatic and unable to tolerate medications, the HEAL-IST Trial is now enrolling. ​

This clinical study is evaluating the safety and effectiveness of a hybrid sinus node-sparing ablation
procedure as a potential treatment option. Learn more about the trial and patient qualifications at: HEAL- IST.com​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=InappropriateSinusTachy…; target='_blank'>#InappropriateSinusTachycardia</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a>​